anti-ulcer agents

Preferred Label : anti-ulcer agents;

MeSH definition : Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief.;

MeSH synonym : anti-ulcer drugs; agents, anti-ulcer; anti ulcer drugs; drugs, anti-ulcer; anti ulcer agents;

MeSH annotation : restrict to gastrointestinal ulcers;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D000897;

UMLS CUI

C0003216;

ATC code(s)
- Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) [ATC Code]
- bismuth subcitrate [ATC Code]
- drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) [ATC Code]
- enprostil [ATC Code]
- misoprostol [ATC Code]
- pirenzepine [ATC Code]
- proglumide [ATC Code]
- prostaglandins [ATC Code]
- sucralfate [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Anti-ulcer Agent [NCIt concept]
Indexing information
- 7-O-trans-cinnamoyl-6beta-hydroxyloganin [MeSH Supplementary Concept]
- dichlorido-zinc(II)-4-(2-(5-methoxybenzylideneamino)ethyl)piperazin-1-iumphenolate [MeSH Supplementary Concept]
- mosapride [MeSH Supplementary Concept]
- propentofylline [MeSH Supplementary Concept]
Record concept(s)
- Anti-Ulcer agents [MeSH concept]
See also
- antacids [MeSH Descriptor]
- epidermal growth factor [MeSH Descriptor]
- histamine h2 antagonists [MeSH Descriptor]
- parasympatholytics [MeSH Descriptor]
- peptic ulcer [MeSH Descriptor]
See also (suggested by CISMeF)
- proton pump inhibitors [MeSH Descriptor]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 11-deoxy-16-phenoxy-17,18,19,20-tetranorprostaglandin E1 [MeSH Supplementary Concept]
- 11-deoxyprostaglandin E1 [MeSH Supplementary Concept]
- 16,16-Dimethylprostaglandin E2 [MeSH Descriptor]
- 5-hydroxymethyluracil [MeSH Supplementary Concept]
- 6-methyluracil [MeSH Supplementary Concept]
- Actovegin [MeSH Supplementary Concept]
- BPC 157 [MeSH Supplementary Concept]
- Ethonium [MeSH Supplementary Concept]
- L 745337 [MeSH Supplementary Concept]
- Pantoprazole [MeSH Descriptor]
- U 74500A [MeSH Supplementary Concept]
- alpha-methylene gamma-butyrolactone [MeSH Supplementary Concept]
- anisodamine [MeSH Supplementary Concept]
- arbaprostil [MeSH Descriptor]
- benzohexonium [MeSH Supplementary Concept]
- benzotript [MeSH Supplementary Concept]
- bismuth tripotassium dicitrate [MeSH Supplementary Concept]
- burimamide [MeSH Descriptor]
- carbenoxolone [MeSH Descriptor]
- cetraxate [MeSH Supplementary Concept]
- cimetidine [MeSH Descriptor]
- cinitapride [MeSH Supplementary Concept]
- cisapride [MeSH Descriptor]
- cyclopentenone [MeSH Supplementary Concept]
- cytomedins [MeSH Supplementary Concept]
- dexlansoprazole [MeSH Descriptor]
- dimephosphon [MeSH Supplementary Concept]
- dimethylpropiothetin [MeSH Supplementary Concept]
- ebrotidine [MeSH Supplementary Concept]
- ebselen [MeSH Supplementary Concept]
- ecabapide [MeSH Supplementary Concept]
- ecabet [MeSH Supplementary Concept]
- enisoprost [MeSH Supplementary Concept]
- enkephalin-Leu, Ala(2)-Arg(6)- [MeSH Supplementary Concept]
- enprostil [MeSH Descriptor]
- esomeprazole [MeSH Descriptor]
- famotidine [MeSH Descriptor]
- fucoidan [MeSH Supplementary Concept]
- gamma-oryzanol [MeSH Supplementary Concept]
- gefarnate [MeSH Descriptor]
- geranylgeranylacetone [MeSH Supplementary Concept]
- irsogladine [MeSH Supplementary Concept]
- lafutidine [MeSH Supplementary Concept]
- lansoprazole [MeSH Descriptor]
- meciadanol [MeSH Supplementary Concept]
- metiamide [MeSH Descriptor]
- mirikizumab [MeSH Supplementary Concept]
- misoprostol [MeSH Descriptor]
- naringenin [MeSH Supplementary Concept]
- nitecapone [MeSH Supplementary Concept]
- nizatidine [MeSH Descriptor]
- omeprazole [MeSH Descriptor]
- oxmetidine [MeSH Supplementary Concept]
- pentacaine [MeSH Supplementary Concept]
- pirenzepine [MeSH Descriptor]
- plaunotol [MeSH Supplementary Concept]
- polaprezinc [MeSH Supplementary Concept]
- proglumide [MeSH Descriptor]
- propantheline [MeSH Descriptor]
- rabeprazole [MeSH Descriptor]
- ranitidine [MeSH Descriptor]
- ranitidine bismuth citrate [MeSH Supplementary Concept]
- rebamipide [MeSH Supplementary Concept]
- rioprostil [MeSH Descriptor]
- rosaprostol [MeSH Supplementary Concept]
- roxatidine acetate [MeSH Supplementary Concept]
- sch 28080 [MeSH Supplementary Concept]
- sodium nucleinate [MeSH Supplementary Concept]
- sofalcone [MeSH Supplementary Concept]
- sucralfate [MeSH Descriptor]
- sucrose octasulfate [MeSH Supplementary Concept]
- sulglicotide [MeSH Supplementary Concept]
- trimoprostil [MeSH Supplementary Concept]
- vitamin U [MeSH Descriptor]
UMLS correspondences (same concept)
- Anti-ulcer Agent [NCIt concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients